Heart Valve Devices Market To Report Impressive Growth, Revenue To Surge To US$10.35 billion by 2022

12-Dec-2017 | Zion Market Research

With the presence of a large pool of participants, the Global heart valve devices market is displaying a highly competitive business landscape, finds a new research report by Zion Market Research (ZMR). Abbott, Medtronic, CryoLife Inc., Boston Scientific Corporation, Micro Interventional Devices Inc., Neovasc Inc., and Edward Lifesciences Corporation are some of the key vendors of heart valve devices across the world. These players are focusing aggressively on innovation, as well as on including advanced technologies in their existing products. Over the coming years, they are also expected to take up partnerships and mergers and acquisitions as their key strategy for business development, states the heart valve devices market study.

In a key boost to heart valve devices market, in September 2018, LivaNova—a medical technology firm—introduced the international pivotal study for determining the application of autonomic regulation treatment for heart failure. Reportedly, the firm entrenched the Vitaria system in a patient during the autonomic regulation treatment to improve myocardial functioning and minimize the cases of progress of heart failures in patients with reduced ejection fraction.

Request Free Sample Request Customization Buy Now

As estimated in this report, the global heart valve devices market stood at US$5.60 billion in 2016. Witnessing a tremendous rise during the period from 2017 to 2022, the revenue in this heart valve devices market is expected to reach US$10.35 billion by the end of the forecast period.

Obese Population & Heart Disorders To Drive Heart Valve Devices Market Size

“Inactive lifestyle of the global population leading to rise in the proportion of obesity among the individuals is expected to propel the growth of heart valve devices market in the years ahead,” says the author of this study. Apart from this, mammoth demand for minimally invasive procedures as a result of increase in cardiac & pathological disorders along with persistent product innovations are few of the key growth drivers of heart valve devices market.

Browse the full " Heart Valve Devices Market by Procedure (Heart Valve Replacement Devices (Mechanical Valve, Bioprosthetic Valve, TAVR) & Position (Mitral Valve, Aortic Valve, Other), Heart valve Repair Devices (Surgical Valve, Balloon Valvuloplasty Devices, TMVR)), by End User (Hospitals and Ambulatory Surgical Centers), and by Region: Global Industry Perspective, Comprehensive Analysis and Forecast, 2016- 2022" report at http://www.zionmarketresearch.com/report/heart-valve-devices-market

Complicated regulatory procedures and high costs of procedures &devices, however, are predicted to restrict the growth of the heart valve devices market in the upcoming years. Nevertheless, heart valve ailments can cause heart failure, blood clots, stroke, and death of patients and hence requires effecting handling of the heart valve disease. This is anticipated to boost heart valve devices market demand in the next few years, thereby normalizing the impact of hindrances on the heart valve devices market, reports the study.


Availability Of Technologically Superior Products To Spur Regional Dominance

Regionally, North America has been leading the worldwide heart valve devices market and is anticipated to continue on the dominant position in the years to come, states the heart valve devices market study. Massive application of technologically superior products and growing incidences of heart diseases in the region is the main factor behind the dominance of the North America heart valve devices market. The presence of market players such as Boston Scientific Corporation, Abbott Laboratories, and Medtronic Incorporation in the countries such as the U.S. in North America is another significant factor that is supporting the growth of this regional heart valve devices market.

The global heart valve devices market is segmented as follows:

By Product

  • Heart Valve Replacement Devices
  • By technique:
    • Mechanical Valve
    • Bioprosthetic Valve
    • TAVR (Transcatheter Aortic Valve Replacement)
  • By Position:
    • Mitral Valve Replacement Devices
    • Aortic Valve Replacement Devices
    • Other Position Heart Valve Replacement Devices
  • Heart Valve Repair Devices
    • Surgical Valve Repair Devices
    • Balloon Valvuloplasty Devices
    • TMVR (Transcatheter Mitral Valve Repair)

By End User

  • Hospital
  • Ambulatory Surgical Centers

By Region

  • North America
    • The U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • The Middle East and Africa

About Us:
Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, the company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.

Contact Us:
Zion Market Research
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651
Email: sales@zionmarketresearch.com
Website: https://www.zionmarketresearch.com

Request Free Brochure
Latest Published Reports

View All Published Reports